Literature DB >> 24173144

KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population.

S D Tao1, Y M He1, Y L Ying1, J He1, F M Zhu1, H J Lv1.   

Abstract

Allelic polymorphism and expression variation of killer cell immunoglobulin-like receptor (KIR) 3DL1 on natural killer (NK) cells differ among populations. To determine whether the phenotypic variants are due to KIR polymorphism, transcription or copy number, the allelic polymorphism, mRNA levels and antigen expression of KIR3DL1 were assessed in 162 individuals. We characterized 13 KIR3DL1 alleles, five of which were novel. In addition, 21 genotypes were identified. The correlation between the binding patterns of NK cells to anti-KIR3DL1 and KIR3DL1 alleles was also examined. NK cells with different 3DL1 alleles showed distinct binding levels to anti-KIR3DL1. The binding frequencies of NK cells to anti-KIR3DL1 were not accordant with their binding levels, but both associated with the allele copy numbers. The mRNA expression amounts of individuals with two copy alleles were higher than those of individuals with one copy allele. Our data indicate that both the allele copy number and polymorphism of KIR3DL1 influence the antigen expression on the NK-cell surface, but only the copy number was associated with mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173144     DOI: 10.1038/gene.2013.55

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

Authors:  Geraldine M O'Connor; Kieran J Guinan; Rodat T Cunningham; Derek Middleton; Peter Parham; Clair M Gardiner
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Authors:  Rasmi Thomas; Eriko Yamada; Galit Alter; Maureen P Martin; Arman A Bashirova; Paul J Norman; Marcus Altfeld; Peter Parham; Stephen K Anderson; Daniel W McVicar; Mary Carrington
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

Authors:  G-Q Wu; Y-M Zhao; X-Y Lai; K-L Yang; F-M Zhu; W Zhang; W Wang; Y Luo; Y-M Tan; Y-J Wang; W-J Cao; H Huang
Journal:  Tissue Antigens       Date:  2009-09-17

5.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.

Authors:  Laure Denis; Katia Gagne; Brigitte Gueglio; Nolwenn Kerdudou; Noel Milpied; Philippe Simon; Gilles Follea; Marc Bonneville; Jean-Luc Harousseau; Jean-Denis Bignon
Journal:  Hum Immunol       Date:  2005-02-19       Impact factor: 2.850

7.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

8.  Determinants of antileukemia effects of allogeneic NK cells.

Authors:  Wing Leung; Rekha Iyengar; Victoria Turner; Peter Lang; Peter Bader; Paul Conn; Dietrich Niethammer; Rupert Handgretinger
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

9.  Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.

Authors:  Deepti Sharma; Karine Bastard; Lisbeth A Guethlein; Paul J Norman; Nobuyo Yawata; Makoto Yawata; Marcelo Pando; Hathairat Thananchai; Tao Dong; Sarah Rowland-Jones; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

10.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Ann-Margaret Little; Fotini Partheniou; Peter Parham
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  7 in total

1.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

2.  KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.

Authors:  Tiernan J Mulrooney; Aaron C Zhang; Yehuda Goldgur; Jeanette E Boudreau; Katharine C Hsu
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

3.  KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.

Authors:  Jeanette E Boudreau; Tiernan J Mulrooney; Jean-Benoît Le Luduec; Edward Barker; Katharine C Hsu
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

4.  KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.

Authors:  Neda Nemat-Gorgani; Hisham A Edinur; Jill A Hollenbach; James A Traherne; Paul P J Dunn; Geoffrey K Chambers; Peter Parham; Paul J Norman
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

5.  High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han.

Authors:  Sudan Tao; Yanmin He; Katherine M Kichula; Jielin Wang; Ji He; Paul J Norman; Faming Zhu
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 6.  Behçet's Disease: Do Natural Killer Cells Play a Significant Role?

Authors:  Harry Petrushkin; Md Samiul Hasan; Miles R Stanford; Farida Fortune; Graham R Wallace
Journal:  Front Immunol       Date:  2015-03-24       Impact factor: 7.561

7.  Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.

Authors:  Zhihui Deng; Jun Zhao; Siqi Cai; Ying Qi; Qiong Yu; Maureen P Martin; Xiaojiang Gao; Rui Chen; Jiacai Zhuo; Jianxin Zhen; Mingjie Zhang; Guobin Zhang; Liumei He; Hongyan Zou; Liang Lu; Weigang Zhu; Wenxu Hong; Mary Carrington; Paul J Norman
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.